Journal of Molecular Endocrinology, ISSN 0952-5041, 08/2011, Volume 47, Issue 1, pp. R11 - R23
The receptor tyrosine kinases (RTKs) play a critical role, controlling cell proliferation, survival, and differentiation of normal cells. Their pivotal...
NPM-ALK | EML4-ALK FUSION GENE | HEAVY-CHAIN GENE | ENDOCRINOLOGY & METABOLISM | INFLAMMATORY MYOFIBROBLASTIC TUMOR | NON-HODGKINS-LYMPHOMA | ALK FUSION | LARGE-CELL LYMPHOMA | GROWTH-FACTOR | RECEPTOR TYROSINE KINASE | SMALL-MOLECULE INHIBITOR | Neoplasms - metabolism | Proto-Oncogene Proteins - metabolism | Translocation, Genetic | Phospholipase C gamma - metabolism | Signal Transduction | src-Family Kinases | Protein-Tyrosine Kinases - metabolism | Pyrazoles | Humans | Transcriptional Activation | Lymphoma - genetics | Up-Regulation - genetics | Intracellular Signaling Peptides and Proteins - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Lymphoma - metabolism | Neoplasms - genetics | Piperidines - pharmacology | Receptor Protein-Tyrosine Kinases - genetics | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Pyridines - pharmacology | Mutation | Proto-Oncogene Proteins p21(ras) - metabolism
NPM-ALK | EML4-ALK FUSION GENE | HEAVY-CHAIN GENE | ENDOCRINOLOGY & METABOLISM | INFLAMMATORY MYOFIBROBLASTIC TUMOR | NON-HODGKINS-LYMPHOMA | ALK FUSION | LARGE-CELL LYMPHOMA | GROWTH-FACTOR | RECEPTOR TYROSINE KINASE | SMALL-MOLECULE INHIBITOR | Neoplasms - metabolism | Proto-Oncogene Proteins - metabolism | Translocation, Genetic | Phospholipase C gamma - metabolism | Signal Transduction | src-Family Kinases | Protein-Tyrosine Kinases - metabolism | Pyrazoles | Humans | Transcriptional Activation | Lymphoma - genetics | Up-Regulation - genetics | Intracellular Signaling Peptides and Proteins - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Lymphoma - metabolism | Neoplasms - genetics | Piperidines - pharmacology | Receptor Protein-Tyrosine Kinases - genetics | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Pyridines - pharmacology | Mutation | Proto-Oncogene Proteins p21(ras) - metabolism
Journal Article
Current Opinion in Hematology, ISSN 1065-6251, 07/2013, Volume 20, Issue 4, pp. 374 - 381
PURPOSE OF REVIEWAnaplastic large cell lymphomas (ALCLs) are rare entities whose somatic genetic lesions have been identified only in a subset of patients....
Signalling pathways | Lymphoid differentiation | Kinase inhibitors | Mouse models | Anaplastic lymphoma kinase | mouse models | ALK | ACTIVATION | RECOGNITION | ABNORMALITIES | TYROSINE KINASE | anaplastic lymphoma kinase | MOUSE | IDENTIFICATION | PERIPHERAL T-CELL | lymphoid differentiation | kinase inhibitors | signalling pathways | GENE | HEMATOLOGY | EXPRESSION | Signal Transduction - physiology | Receptor Protein-Tyrosine Kinases - genetics | Cell Transformation, Neoplastic - genetics | Humans | Receptor Protein-Tyrosine Kinases - physiology | Lymphoma, Large-Cell, Anaplastic - genetics
Signalling pathways | Lymphoid differentiation | Kinase inhibitors | Mouse models | Anaplastic lymphoma kinase | mouse models | ALK | ACTIVATION | RECOGNITION | ABNORMALITIES | TYROSINE KINASE | anaplastic lymphoma kinase | MOUSE | IDENTIFICATION | PERIPHERAL T-CELL | lymphoid differentiation | kinase inhibitors | signalling pathways | GENE | HEMATOLOGY | EXPRESSION | Signal Transduction - physiology | Receptor Protein-Tyrosine Kinases - genetics | Cell Transformation, Neoplastic - genetics | Humans | Receptor Protein-Tyrosine Kinases - physiology | Lymphoma, Large-Cell, Anaplastic - genetics
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.